IFNA17 and alcoholic fatty liver disease: One retrospective cohort study showed an association between IFNα inhalation and lower risks of elevated alanine aminotransferase (>40 U/L) in patients aged between 32 and 56 with (n = 86) and without non-alcoholic fatty liver disease (n = 194) [30].